Search results
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold | The Motley Fool
The Motley Fool· 3 days agoInvestors looking for high-yield dividend stocks to buy now should turn their attention toward the...
Pfizer And Five Other Dividend-Yield Standouts
Forbes· 1 day ago“Would you kindly do a piece on high dividend stocks,” a reader asked recently. My favorite high-divided stock at the moment is Pfizer
Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks
The Motley Fool via AOL· 2 days agoThe average yield on debt investments in PennantPark's debt portfolio...was on non-accrual status at...
Miller Howard Investments Inc. NY Purchases 1,134 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 6 hours agoMiller Howard Investments Inc. NY lifted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 6.6% during the 1st quarter, according to its most recent disclosure ...
7 Dividend Stocks to Buy Now: June 2024
InvestorPlace· 2 days agoThese dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.
2 Beaten-Down Growth Stocks to Buy Without Hesitation in the 2024 Bull Market
Motley Fool via Yahoo Finance· 1 day agoManagement also expects that its ongoing cost-cutting efforts will save the business $4 billion this...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoThat's great news, especially considering Pfizer's forward yield already tops 6% at the current share price. What do you get when you ...
Skip Meme Mania: 3 Undervalued Blue-Chip Stocks for Steady Returns
InvestorPlace· 5 days agoOn the other hand, investing in penny and meme stocks is exciting and attracts investors. Of course,...
3 Underrated Dividend Stock Machines to Turbocharge Your Income
InvestorPlace· 5 days agoOne of them is dividend stocks but you do not want to bet your money on companies that have...
Apella Capital LLC Trims Stock Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 3 days ago(NYSE:PFE – Free Report) by 3.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,753 shares of the biopharmaceutical ...